Oxidative and nitrosative events in asthma

Free Radical Biology and Medicine

Volumn 35, Issue 3, 2003, Pages 213-225

  Andreadis, Athena A ^a   Hazen, Stanley L ^a   Comhair, Suzy A A ^a   Erzurum, Serpil C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Asthma; Eosinophil specific peroxidase; Free radicals; Inflammation; Nitric oxide; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

CALCIUM; CORTICOSTEROID; CROMOGLYCATE DISODIUM; MANGANESE DERIVATIVE; NEDOCROMIL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AIRWAY CONSTRICTION; ALLERGIC ASTHMA; ANTIOXIDANT ACTIVITY; ASTHMA; ATOPY; BRONCHUS BIOPSY; CALCIUM CELL LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DRUG TOLERANCE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; INFLAMMATORY INFILTRATE; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; NITRATION; NOCTURNAL ASTHMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REMISSION; RESPIRATORY EPITHELIUM; REVIEW; SIDE EFFECT; TRACHEOBRONCHIAL TOILET; TRANSCRIPTION INITIATION;

EID: 0142043917     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00278-8     Document Type: Article

References (158)

1. Mannino D.M., Homa D.M., Akinbami L.J., Moorman J.E., Gwynn C., Redd S.C. Surveillance for asthma - United States, 1980-1999. MMWR Surveill. Summ. 51:2002;1-13.
2. Dweik R.A., Laskowski D., Abu-Soud H.M., Kaneko F., Hutte R., Stuehr D.J., Erzurum S.C. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J. Clin. Invest. 101:1998;660-666.
3. Dweik R.A., Comhair S.A., Gaston B., Thunnissen F.B., Farver C., Thomassen M.J., Kavuru M., Hammel J., Abu-Soud H.M., Erzurum S.C. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc. Natl. Acad. Sci. USA. 98:2001;2622-2627.
4. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 343:1994;133-135.
5. Massaro A.F., Mehta S., Lilly C.M., Kobzik L., Reilly J.J., Drazen J.M. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am. J. Respir. Crit. Care Med. 153:1996;1510-1514.
6. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
7. Mehta S., Lilly C.M., Rollenhagen J.E., Haley K.J., Asano K., Drazen J.M. Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am. J. Physiol. 272:1997;L124-L131.
8. Sanders S.P. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? Am. J. Respir. Cell Mol. Biol. 21:1999;147-149.
9. Silkoff P.E., Sylvester J.T., Zamel N., Permutt S. Airway nitric oxide diffusion in asthma role in pulmonary function and bronchial responsiveness . Am. J. Respir. Crit. Care Med. 161:2000;1218-1228.
10. Stuehr D.J. Mammalian nitric oxide synthases. Biochim. Biophys. Acta. 1411:1999;217-230.
11. Uetani K., Der S.D., Zamanian-Daryoush M., de La Motte C., Lieberman B.Y., Williams B.R., Erzurum S.C. Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J. Immunol. 165:2000;988-996.
12. Persson M.G., Zetterstrom O., Agrenius V., Ihre E., Gustafsson L.E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 343:1994;146-147.
13. Hockey, P. M.; Djukanovic, R.; Roche, W. R.; Holgate, S. T. Airway remodeling and repair. In: Denburg, J. A., ed. Allergy and allergic diseases: the new mechanisms and therapeutics. Totowa, NJ: Humana Press Inc.; 1998:567-579.
14. Comhair S.A., Bhathena P.R., Dweik R.A., Kavuru M., Erzurum S.C. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet. 355:2000;624.
15. Guo F.H., Comhair S.A., Zheng S., Dweik R.A., Eissa N.T., Thomassen M.J., Calhoun W., Erzurum S.C. Molecular mechanisms of increased nitric oxide (NO) in asthma evidence for transcriptional and post-translational regulation of NO synthesis . J. Immunol. 164:2000;5970-5980.
16. Freeman B.A., White C.R., Gutierrez H., Paler-Martinez A., Tarpey M.M., Rubbo H. Oxygen radical-nitric oxide reactions in vascular diseases. Adv. Pharmacol. 34:1995;45-69.
17. MacPherson J.C., Comhair S.A., Erzurum S.C., Klein D.F., Lipscomb M.F., Kavuru M.S., Samoszuk M.K., Hazen S.L. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma characterization of pathways available to eosinophils for generating reactive nitrogen species . J. Immunol. 166:2001;5763-5772.
18. Wu W., Samoszuk M.K., Comhair S.A., Thomassen M.J., Farver C.F., Dweik R.A., Kavuru M.S., Erzurum S.C., Hazen S.L. Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Invest. 105:2000;1455-1463.
19. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am. J. Respir. Crit. Care Med. 161:2000;694-699.
20. Halliwell B. Free radicals, antioxidants, and human disease curiosity, cause, or consequence? Lancet. 344:1994;721-724.
21. Conner E.M., Grisham M.B. Inflammation, free radicals, and antioxidants. Nutrition. 12:1996;274-277.
22. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
23. Babior B.M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:(Part 2):1978;721-725.
24. Davies K.J. Oxidative stress the paradox of aerobic life . Biochem. Soc. Symp. 61:1995;1-31.
25. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
26. Antczak A., Nowak D., Shariati B., Krol M., Piasecka G., Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur. Respir. J. 10:1997;1235-1241.
27. Calhoun W.J., Reed H.E., Moest D.R., Stevens C.A. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145:1992;317-325.
28. Fahy J.V., Liu J., Wong H., Boushey H.A. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. 147:1993;1126-1131.
29. Postma D.S., Renkema T.E., Noordhoek J.A., Faber H., Sluiter H.J., Kauffman H. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am. Rev. Respir. Dis. 137:1988;57-61.
30. Sanders S.P., Zweier J.L., Harrison S.J., Trush M.A., Rembish S.J., Liu M.C. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am. J. Respir. Crit. Care Med. 151:1995;1725-1733.
31. Comhair S.A., Bhathena P.R., Farver C., Thunnissen F.B., Erzurum S.C. Extracellular glutathione peroxidase induction in asthmatic lungs evidence for redox regulation of expression in human airway epithelial cells . FASEB J. 15:2001;70-78.
32. Nathan C., Xie Q.W. Nitric oxide synthases roles, tolls, and controls . Cell. 78:1994;915-918.
33. Kharitonov S.A., O'Connor B.J., Evans D.J., Barnes P.J. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 151:1995;1894-1899.
34. Khatri S.B., Ozkan M., McCarthy K., Laskowski D., Hammel J., Dweik R.A., Erzurum S.C. Alterations in exhaled gas profile during allergen-induced asthmatic response. Am. J. Respir. Crit. Care Med. 164:2001;1844-1848.
35. Barnes P.J. Nitric oxide and asthma. Res. Immunol. 146:1995;698-702.
36. Kobzik L., Bredt D.S., Lowenstein C.J., Drazen J., Gaston B., Sugarbaker D., Stamler J.S. Nitric oxide synthase in human and rat lung immunocytochemical and histochemical localization . Am. J. Respir. Cell Mol. Biol. 9:1993;371-377.
37. Grasemann H., Yandava C.N., Storm van's Gravesande K., Deykin A., Pillari A., Ma J., Sonna L.A., Lilly C., Stampfer M.J., Israel E., Silverman E.K., Drazen J.M. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem. Biophys. Res. Commun. 272:2000;391-394.
38. Guo F.H., Uetani K., Haque S.J., Williams B.R., Dweik R.A., Thunnissen F.B., Calhoun W., Erzurum S.C. Interferon-γ and interleukin-4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100:1997;829-838.
39. Marks-Konczalik J., Chu S.C., Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J. Biol. Chem. 273:1998;22201-22208.
40. Taylor B.S., de Vera M.E., Ganster R.W., Wang Q., Shapiro R.A., Morris S.M. Jr., Billiar T.R., Geller D.A. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273:1998;15148-15156.
41. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779-1784.
42. Crystal R.G. Research opportunities and advances in lung disease. JAMA. 285:2001;612-618.
43. Molina y Vedia L., McDonald B., Reep B., Brune B., Di Silvio M., Billiar T.R., Lapetina E.G. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3- phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267:1992;24929-24932.
44. Liu L., Hausladen A., Zeng M., Que L., Heitman J., Stamler J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 410:2001;490-494.
45. Crow J.P., Beckman J.S. Reactions between nitric oxide, superoxide, and peroxynitrite footprints of peroxynitrite in vivo . Adv. Pharmacol. 34:1995;17-43.
46. Radi R., Denicola A., Freeman B.A. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol. 301:1999;353-367.
47. Rochelle L.G., Fischer B.M., Adler K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic. Biol. Med. 24:1998;863-868.
48. Souza J.M., Daikhin E., Yudkoff M., Raman C.S., Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch. Biochem. Biophys. 371:1999;169-178.
49. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 269:1994;29409-29415.
50. Saleh D., Ernst P., Lim S., Barnes P.J., Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase effect of inhaled glucocorticoid . FASEB J. 12:1998;929-937.
51. Kaminsky D.A., Mitchell J., Carroll N., James A., Soultanakis R., Janssen Y. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J. Allergy Clin. Immunol. 104:1999;747-754.
52. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite the good, the bad, and ugly . Am. J. Physiol. 271:1996;C1424-C1437.
53. Halliwell B., Zhao K., Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier, and the not so good a personal view of recent controversies . Free Radic. Res. 31:1999;651-669.
54. Ischiropoulos H. Biological tyrosine nitration a pathophysiological function of nitric oxide and reactive oxygen species . Arch. Biochem. Biophys. 356:1998;1-11.
55. Aulak K.S., Miyagi M., Yan L., West K.A., Massillon D., Crabb J.W., Stuehr D.J. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc. Natl. Acad. Sci. USA. 98:2001;12056-12061.
56. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA. 93:1996;11853-11858.
57. Koarai A., Ichinose M., Sugiura H., Tomaki M., Watanabe M., Yamagata S., Komaki Y., Shirato K., Hattori T. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Eur. Respir. J. 20:2002;609-616.
58. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., Hazen S.L. A tale of two controversies defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species . J. Biol. Chem. 277:2002;17415-17427.
59. Gaston B., Drazen J.M., Loscalzo J., Stamler J.S. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:1994;538-551.
60. Freeman B.A., Crapo J.D. Biology of disease free radicals and tissue injury . Lab. Invest. 47:1982;412-426.
61. Bradley B.L., Azzawi M., Jacobson M., Assoufi B., Collins J.V., Irani A.M., Schwartz L.B., Durham S.R., Jeffery P.K., Kay A.B. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness . J. Allergy Clin. Immunol. 88:1991;661-674.
62. Lacoste J.Y., Bousquet J., Chanez P., Van Vyve T., Simony-Lafontaine J., Lequeu N., Vic P., Enander I., Godard P., Michel F.B. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 92:1993;537-548.
63. Koh Y.Y., Dupuis R., Pollice M., Albertine K.H., Fish J.E., Peters S.P. Neutrophils recruited to the lungs of humans by segmental antigen challenge display a reduced chemotactic response to leukotriene B4. Am. J. Respir. Cell Mol. Biol. 8:1993;493-499.
64. Montefort S., Gratziou C., Goulding D., Polosa R., Haskard D.O., Howarth P.H., Holgate S.T., Carroll M.P. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93:1994;1411-1421.
65. Martin R.J., Cicutto L.C., Smith H.R., Ballard R.D., Szefler S.J. Airways inflammation in nocturnal asthma. Am. Rev. Respir. Dis. 143:1991;351-357.
66. Foresi A., Bertorelli G., Pesci A., Chetta A., Olivieri D. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. Chest. 98:1990;528-535.
67. Tanizaki Y., Kitani H., Mifune T., Mitsunobu F., Kajimoto K., Sugimoto K. Effects of glucocorticoids on humoral and cellular immunity and on airway inflammation in patients with steroid-dependent intractable asthma. J. Asthma. 30:1993;485-492.
68. Wardlaw A.J. Eosinophils in the 1990s new perspectives on their role in health and disease . Postgrad. Med. J. 70:1994;536-552.
69. Horwitz R.J., Busse W.W. Inflammation and asthma. Clin. Chest Med. 16:1995;583-602.
70. Gleich G.J., Ottesen E.A., Leiferman K.M., Ackerman S.J. Eosinophils and human disease. Int. Arch. Allergy Appl. Immunol. 88:1989;59-62.
71. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:2000;1720-1745.
72. Hamann K.J., Strek M.E., Baranowski S.L., Munoz N.M., Williams F.S., White S.R., Vita A., Leff A.R. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am. J. Physiol. 265:1993;L301-L307.
73. Bousquet J., Van Vyve T., Chanez P., Enander I., Michel F.B., Godard P. Cells and mediators in bronchoalveolar lavage of asthmatic patients the example of eosinophilic inflammation . Allergy. 48:1993;70-76.
74. Griffin E., Hakansson L., Formgren H., Jorgensen K., Peterson C., Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J. Allergy Clin. Immunol. 87:1991;548-557.
75. Sanz M.L., Parra A., Prieto I., Dieguez I., Oehling A.K. Serum eosinophil peroxidase (EPO) levels in asthmatic patients. Allergy. 52:1997;417-422.
76. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:1988;62-69.
77. Durack D.T., Sumi S.M., Klebanoff S.J. Neurotoxicity of human eosinophils. Proc. Natl. Acad. Sci. USA. 76:1979;1443-1447.
78. Davis W.B., Fells G.A., Sun X.H., Gadek J.E., Venet A., Crystal R.G. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J. Clin. Invest. 74:1984;269-278.
79. Ayars G.H., Altman L.C., Gleich G.J., Loegering D.A., Baker C.B. Eosinophil- and eosinophil granule-mediated pneumocyte injury. J. Allergy Clin. Immunol. 76:1985;595-604.
80. Agosti J.M., Altman L.C., Ayars G.H., Loegering D.A., Gleich G.J., Klebanoff S.J. The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J. Allergy Clin. Immunol. 79:1987;496-504.
81. Brottman G.M., Regelmann W.E., Slungaard A., Wangensteen O.D. Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig. Pediatr. Pulmonol. 21:1996;159-166.
82. Laitinen L.A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131:1985;599-606.
83. Hirata A., Motojima S., Fukuda T., Makino S. Damage to respiratory epithelium by guinea-pig eosinophils stimulated with IgG-coated Sepharose beads. Clin. Exp. Allergy. 26:1996;848-858.
84. Blyth D.I., Pedrick M.S., Savage T.J., Hessel E.M., Fattah D. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14:1996;425-438.
85. Yoshikawa S., Kayes S.G., Parker J.C. Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and vasoconstriction unaffected by eosinophil peroxidase inhibition. Am. Rev. Respir. Dis. 147:1993;914-920.
86. Spector A.A., Gordon J.A., Moore S.A. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid Res. 27:1988;271-323.
87. Shaw R.J., Walsh G.M., Cromwell O., Moqbel R., Spry C.J., Kay A.B. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature. 316:1985;150-152.
88. Dahlen S.E., Hedqvist P., Hammarstrom S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 288:1980;484-486.
89. Cuss F.M., Dixon C.M., Barnes P.J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 2:1986;189-192.
90. Babior B.M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:(Part 1):1978;659-668.
91. Klebanoff, S. J.; Clark, R. A. The neutrophil: function and clinical disorders. Elsevier/North Holland Biomedical Press; 1978:447-451.
92. Oxvig C., Thomsen A.R., Overgaard M.T., Sorensen E.S., Hojrup P., Bjerrum M.J., Gleich G.J., Sottrup-Jensen L. Biochemical evidence for heme linkage through esters with Asp-93 and Glu-241 in human eosinophil peroxidase. The ester with Asp-93 is only partially formed in vivo. J. Biol. Chem. 274:1999;16953-16958.
93. Heinecke J.W., Li W., Francis G.A., Goldstein J.A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91:1993;2866-2872.
94. Wu W., Chen Y., Hazen S.L. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J. Biol. Chem. 274:1999;25933-25944.
95. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103:1999;1547-1560.
96. Abu-Soud H.M., Khassawneh M.Y., Sohn J.T., Murray P., Haxhiu M.A., Hazen S.L. Peroxidases inhibit nitric oxide (NO) dependent bronchodilation development of a model describing NO-peroxidase interactions . Biochemistry. 40:2001;11866-11875.
97. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:1994;20394-20400.
98. Schmitt D., Shen Z., Zhang R., Colles S.M., Wu W., Salomon R.G., Chen Y., Chisolm G.M., Hazen S.L. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry. 38:1999;16904-16915.
99. Brennan M.L., Anderson M.M., Shih D.M., Qu X.D., Wang X., Mehta A.C., Lim L.L., Shi W., Hazen S.L., Jacob J.S., Crowley J.R., Heinecke J.W., Lusis A.J. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107:2001;419-430.
100. Weiss S.J., Test S.T., Eckmann C.M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science. 234:1986;200-203.
101. Mayeno A.N., Curran A.J., Roberts R.L., Foote C.S. Eosinophils preferentially use bromide to generate halogenating agents. J. Biol. Chem. 264:1989;5660-5668.
102. Linder, M. Nutritional biochemistry and metabolism. New York: Elsevier Science Inc.; 1992:98-128.
103. Harrison J.E., Schultz J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1976;1371-1374.
104. Aldridge R., Chan T., van Dalen C., Senthilmohan R., Winn M., Venge P., Town G., Kettle A. Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. Free Radic. Biol. Med. 33:2002;847.
105. Denzler K.L., Borchers M.T., Crosby J.R., Cieslewicz G., Hines E.M., Justice J.P., Cormier S.A., Lindenberger K.A., Song W., Wu W., Hazen S.L., Gleich G.J., Lee J.J., Lee N.A. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J. Immunol. 167:2001;1672-1682.
106. Stelts D., Egan R.W., Falcone A., Garlisi C.G., Gleich G.J., Kreutner W., Kung T.T., Nahrebne D.K., Chapman R.W., Minnicozzi M. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 18:1998;463-470.
107. Malm-Erjefalt M., Persson C.G., Erjefalt J.S. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 24:2001;352-359.
108. Abu-Soud H.M., Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. 275:2000;37524-37532.
109. Abu-Soud H.M., Hazen S.L. Nitric oxide modulates the catalytic activity of myeloperoxidase. J. Biol. Chem. 275:2000;5425-5430.
110. Salathe M., Holderby M., Forteza R., Abraham W.M., Wanner A., Conner G.E. Isolation and characterization of a peroxidase from the airway. Am. J. Respir. Cell Mol. Biol. 17:1997;97-105.
111. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science. 296:2002;2391-2394.
112. Hall H.G. Hardening of the sea urchin fertilization envelope by peroxidase-catalyzed phenolic coupling of tyrosines. Cell. 15:1978;343-355.
113. Wallace G., Fry S.C. Phenolic components of the plant cell wall. Int. Rev. Cytol. 151:1994;229-267.
114. van Dalen C.J., Winterbourn C.C., Senthilmohan R., Kettle A.J. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J. Biol. Chem. 275:2000;11638-11644.
115. Vignola A.M., Bonanno A., Mirabella A., Riccobono L., Mirabella F., Profita M., Bellia V., Bousquet J., Bonsignore G. Increased levels of elastase and α1-antitrypsin in sputum of asthmatic patients. Am. J. Respir. Crit. Care Med. 157:1998;505-511.
116. Vignola A.M., Riccobono L., Mirabella A., Profita M., Chanez P., Bellia V., Mautino G., D'accardi P., Bousquet J., Bonsignore G. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 158:1998;1945-1950.
117. Meerschaert J., Kelly E.A., Mosher D.F., Busse W.W., Jarjour N.N. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 159:1999;619-625.
118. Kelly E.A., Busse W.W., Jarjour N.N. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am. J. Respir. Crit. Care Med. 162:2000;1157-1161.
119. Chu H.W., Trudeau J.B., Balzar S., Wenzel S.E. Peripheral blood and airway tissue expression of transforming growth factor β by neutrophils in asthmatic subjects and normal control subjects. J. Allergy Clin. Immunol. 106:2000;1115-1123.
120. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:2001;41279-41287.
121. Shabani F., McNeil J., Tippett L. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. Free Radic. Res. 28:1998;115-123.
122. Zaslow M.C., Clark R.A., Stone P.J., Calore J.D., Snider G.L., Franzblau C. Human neutrophil elastase does not bind to α1-protease inhibitor that has been exposed to activated human neutrophils. Am. Rev. Respir. Dis. 128:1983;434-439.
123. Lawrence D.A., Loskutoff D.J. Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry. 25:1986;6351-6355.
124. Clark R.A., Stone P.J., El Hag A., Calore J.D., Franzblau C. Myeloperoxidase-catalyzed inactivation of α1-protease inhibitor by human neutrophils. J. Biol. Chem. 256:1981;3348-3353.
125. Campbell E.J., Senior R.M., McDonald J.A., Cox D.L. Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J. Clin. Invest. 70:1982;845-852.
126. Heffner J.E., Repine J.E. Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 140:1989;531-554.
127. De Raeve H.R., Thunnissen F.B., Kaneko F.T., Guo F.H., Lewis M., Kavuru M.S., Secic M., Thomassen M.J., Erzurum S.C. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium correction by inhaled corticosteroid in vivo . Am. J. Physiol. 272:1997;L148-L154.
128. Smith L.J., Shamsuddin M., Sporn P.H., Denenberg M., Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic. Biol. Med. 22:1997;1301-1307.
129. Smith L.J., Houston M., Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am. Rev. Respir. Dis. 147:1993;1461-1464.
130. Cantin A.M., North S.L., Fells G.A., Hubbard R.C., Crystal R.G. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1987;1665-1673.
131. Salvemini D., Wang Z.Q., Zweier J.L., Samouilov A., Macarthur H., Misko T.P., Currie M.G., Cuzzocrea S., Sikorski J.A., Riley D.P. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science. 286:1999;304-306.
132. Ren B., Huang W., Akesson B., Ladenstein R. The crystal structure of seleno-glutathione peroxidase from human plasma at 2.9 A resolution. J. Mol. Biol. 268:1997;869-885.
133. Beutler E., Matsumoto F. Ethnic variation in red cell glutathione peroxidase activity. Blood. 46:1975;103-110.
134. Duan Y.J., Komura S., Fiszer-Szafarz B., Szafarz D., Yagi K. Purification and characterization of a novel monomeric glutathione peroxidase from rat liver. J. Biol. Chem. 263:1988;19003-19008.
135. Yoshimura S., Suemizu H., Taniguchi Y., Arimori K., Kawabe N., Moriuchi T. The human plasma glutathione peroxidase-encoding gene organization, sequence, and localization to chromosome 5q32 . Gene. 145:1994;293-297.
136. Comhair S.A., Thomassen M.J., Erzurum S.C. Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O(2) or cigarette smoke. Am. J. Respir. Cell Mol. Biol. 23:2000;350-354.
137. Avissar N., Finkelstein J.N., Horowitz S., Willey J.C., Coy E., Frampton M.W., Watkins R.H., Khullar P., Xu Y.L., Cohen H.J. Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am. J. Physiol. 270:1996;L173-L182.
138. Howlett C.E., Hutchison J.S., Veinot J.P., Chiu A., Merchant P., Fliss H. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am. J. Physiol. 277:1999;L596-L605.
139. Capellier G., Maupoil V., Boillot A., Kantelip J.P., Rochette L., Regnard J., Barale F. L-NAME aggravates pulmonary oxygen toxicity in rats. Eur. Respir. J. 9:1996;2531-2536.
140. Thomassen M.J., Buhrow L.T., Connors M.J., Kaneko F.T., Erzurum S.C., Kavuru M.S. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17:1997;279-283.
141. Raychaudhuri B., Dweik R., Connors M.J., Buhrow L., Malur A., Drazba J., Arroliga A.C., Erzurum S.C., Kavuru M.S., Thomassen M.J. Nitric oxide blocks nuclear factor-κB activation in alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 21:1999;311-316.
142. Sato E., Simpson K.L., Grisham M.B., Koyama S., Robbins R.A. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J. Biol. Chem. 275:2000;10826-10830.
143. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272:1997;31138-31148.
144. Repine J.E., Bast A., Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative stress study group. Am. J. Respir. Crit. Care Med. 156:1997;341-357.
145. Wink D.A., Hanbauer I., Grisham M.B., Laval F., Nims R.W., Laval J., Cook J., Pacelli R., Liebmann J., Krishna M., Ford P.C., Mitchell J.B. Chemical biology of nitric oxide regulation and protective and toxic mechanisms . Curr. Top. Cell Regul. 34:1996;159-187.
146. van der Vliet A., Eiserich J.P., Shigenaga M.K., Cross C.E. Reactive nitrogen species and tyrosine nitration in the respiratory tract epiphenomena or a pathobiologic mechanism of disease? Am. J. Respir. Crit. Care Med. 160:1999;1-9.
147. National Heart, Lung and Blood Institute National Asthma Education Program Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; May 1997, Publication No. 97-4051A.
148. Khatri S.B. Erzurum S. C. Alternative therapies for corticosteroid- dependent asthma. Clin. Pulmon. Med. 6:1999;271-277.
149. Sedgwick J.B., Calhoun W.J., Vrtis R.F., Bates M.E., McAllister P.K., Busse W.W. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:1992;3710-3718.
150. Larsen G.L., White C.W., Takeda K., Loader J.E., Nguyen D.D., Joetham A., Groner Y., Gelfand E.W. Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L350-L359.
151. Roberts M.C., Pang Y., Riley D.E., Hillier S.L., Berger R.C., Krieger J.N. Detection of Tet M and Tet O tetracycline resistance genes by polymerase chain reaction. Mol. Cell. Probes. 7:1993;387-393.
152. Baker K., Marcus C.B., Huffman K., Kruk H., Malfroy B., Doctrow S.R. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model a key role for reactive oxygen species in ischemic brain injury . J. Pharmacol. Exp. Ther. 284:1998;215-221.
153. Melov S., Ravenscroft J., Malik S., Gill M.S., Walker D.W., Clayton P.E., Wallace D.C., Malfroy B., Doctrow S.R., Lithgow G.J. Extension of life-span with superoxide dismutase/catalase mimetics. Science. 289:2000;1567-1569.
154. Batinic-Haberle I., Benov L., Spasojevic I., Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J. Biol. Chem. 273:1998;24521-24528.
155. Batinic-Haberle I. Manganese porphyrins and related compounds as mimics of superoxide dismutase. Methods Enzymol. 349:2002;223-233.
156. Spasojevic I., Batinic-Haberle I., Stevens R.D., Hambright P., Thorpe A.N., Grodkowski J., Neta P., Fridovich I. Manganese(III) biliverdin IX dimethyl ester a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple . Inorg. Chem. 40:2001;726-739.
157. Masini, E.; Vannaci, A.; Bani, D.; Mannaioni, P. F.; Salvemini, D. Prevention of antigen-induced early obstructive reaction by inhaled M40419 in actively sensitized guinea-pigs. Respir. Crit. Care Med. 165:A813; 2002.
158. Masini E., Cuzzocrea S., Mazzon E., Marzocca C., Mannaioni P.F., Salvemini D. Protective effects of M40403, a selective superoxide dismutase